1. Increasing Customer Successes Through Enhanced QC Agility and Flexibility

    Daniel Dixon, Vice President of Quality Control, UPM Pharmaceuticals, explains the importance of QC in CDMOs. 

  2. Product and Service Concepts Driving Speed to Market

    Jonathan Gilinski, Executive Director of CapsCanada explains how to accelerate timelines.

  3. Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing

    Richard Snyder, Sushma Ogram, and Tony DeFusco of Brammer Bio highlight the analytical techniques involved in viral vector production.

  4. Meeting Regulatory Requirements: Rising to the Challenge with a Trusted Equipment Partner

    Equipment upgrades are key to new regulatory requirements, according to Adam Covitt, Vice President of Federal Equipment Company.

  5. Flexible Partnership, Inflexible Quality
    Driven by the demand for biologics, most of which still require parenteral administration, the sterile injectable market is projected to continue its 6% annual growth through 2020.
  6. Aligning with Sponsors for Strategic Growth
    Syed T. Husain, Chief Commercial Officer, and Catherine Hanley, Head of Marketing & Corporate Communications, Alcami, discuss the new company sponsorship.
  7. FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

    The ID CORE XT kit will benefit patients who require ongoing transfusions including individuals with hemoglobinopathies such as sickle-cell disease (SCD) and thalassemia. 

  8. GSK Funds British Biotech Sitryx

    Immunometabolism start-up completes $30 million funding round.

  9. New Diabetes Drug Shows Promise in Phase 2 Study

    Eli Lilly and Company's dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA) LY3298176 led to lowered blood sugar levels and weight loss.

  10. Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma

    STRO-001 is a potential first-in-class antibody drug conjugate (ADC) targeting CD74, a protein highly expressed in B-cell malignancies such as multiple myeloma.

  11. Continuing on the Acquisition Trail: Building Out a World-Class, Customer-Oriented CDMO

    Tim Tyson, Chairman and CEO of Avara Pharmaceutical Services, discusses the company's acquisition strategy.

  12. Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector

    Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE, outlines the advantages of a dedicated CDMO.

  13. Understanding the Unique Design and Engineering Needs for Gene Therapy Production

    Designing gene therapy manufacturing facilities presents unique challenges, says Peter Walters, Lead Process Engineer, CRB USA.

  14. Aspects to Consider on the Way to a Tailored Manufacturing Strategy

    David Brett, Team Leader Product and Service Management at Vetter Pharma International GmbH, discusses strategies in outsourced manufacturing.

  15. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 years old

    Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

  16. Global Pediatric Vaccine Market 2015-2024: Technologic Advancements and Increase in Government and Non-Government Funding

    Global pediatric vaccine market is expected to grow with a CAGR of around 12.6% over the forecast period 2017-2024. 

  17. New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD

    Allergan is evaluating the use of biomarkers for the prediction of response to its IL-23 candidate brazikumab in patients with inflammatory bowel disease (IBD).

  18. U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar

    National contract was won due to its attractive pricing offer.

  19. Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials

    Ariette van Strien, Chief Commercial Officer, Marken, discusses siteless/hybrid clinical trials.

  20. Leveraging Offsite Fabrication in the Pharma Industry

    Offsite fabrication of facility components and equipment can help drug manufacturers achieve their goals, says Dennis Kearney, Pharmaceutical Core Team Leader at CRB USA.

Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.

FDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid

Oct 16, 2018 11:59:49 AM PAO-M10-18-NI-015

New Collaboration Aimed at Improving Cancer Diagnostics in the UK

Oct 16, 2018 11:57:19 AM PAO-M10-18-NI-014
Artificial Intelligence

UK Hospital to Get Command Center Driven by AI and Real-Time Analytics

Oct 16, 2018 11:53:40 AM PAO-M10-18-NI-013
Clinical Trials

New Diabetes Drug Shows Promise in Phase 2 Study

Oct 16, 2018 11:46:31 AM PAO-M10-18-NI-012

GSK Funds British Biotech Sitryx

Oct 16, 2018 11:26:15 AM PAO-M10-18-NI-011
Clinical Trials

New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD

Oct 12, 2018 2:22:42 PM PAO-M10-18-NI-009

Janssen Collaborates on RNA Therapy

Oct 11, 2018 2:28:39 PM PAO-M10-18-NI-008
Speed to Market

Product and Service Concepts Driving Speed to Market

Oct 8, 2018 11:48:41 AM PAO-M10-18-CL-001

Proposed Opioid Bill Includes New Payment Disclosures

Oct 4, 2018 11:12:30 AM PAO-M10-18-NI-007

FluMist Shipped by AstraZeneca

Oct 4, 2018 11:06:03 AM PAO-M10-18-NI-007
Digital Health

Roche Collaborates in Digital Health

Oct 4, 2018 11:02:45 AM PAO-M10-18-NI-006
FDA Approval

New Treatment Option for Migraine Suffers

Oct 4, 2018 11:00:24 AM PAO-M10-18-NI-005
FDA Approval

Another PD-1/L1 Drug Gets Priority Approval from the US FDA

Oct 4, 2018 10:56:10 AM PAO-M10-18-NI-004

Nobel Prize in Medicine Goes to Immunotherapy Developers

Oct 4, 2018 10:51:09 AM PAO-M10-18-NI-003

Nice Insight Overview

Patient Centricity and the Pharmaceutical Supply Chain: An Evolving Dynamic
Becoming a true patient-centric industry requires significant effort and a complete change in the way pharmaceutical companies operate.

Outsourcing Solutions

Leveraging Offsite Fabrication in the Pharma Industry

Investment Watch

The Biotech Boom
Emilie Branch, Strategic Content Manager, Nice Insight
Biotech IPOs are commanding a larger market share than the year before — and this trend shows no signs of slowing down.

Regulatory Spotlight

Competitive Generic Therapy: A New Patient-Centric FDA Pathway

David Alvaro, Ph.D., Scientific Editorial Director, Nice Insight